glp-1 for iih GLP-1's and : r/iih Treatment with GLP-1 receptor agonists
Description
& Thorens, B

On April 30, 2026, the FDA announced a formal proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List - the regulatory mechanism that governs which bulk substances large-scale 503B outsourcing facilities may use in compounding

Your morning catch-up: Dallas private investment firm Highlander Partners is betting on Tapato, outlines of a peace deal emerge with major concessions to Iran and more big stories Based on stories like Awadallas, its no wonder so many people are curious about microdosing GLP-1s through their doctor, telehealth companies and illegal suppliers
The mean age of participants was 54 years, the mean body mass index was 35.5 kg/m, 50 per cent of participants were female and 9.2 per cent had type 2 diabetes

It was demonstrated, that metabolic disturbances in hypothalamic astrocytes, caused either by selective knock-out of insulin receptors or decreased generation of reactive oxygen species (ROS) modulated glucose transport via BBB and also led to modification in behavioral responses in experimental animals [95, 96]
